7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
HIV Seropositivity D006679 15 associated lipids
Biliary Atresia D001656 4 associated lipids
Cachexia D002100 21 associated lipids
Addison Disease D000224 3 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Alveolar Bone Loss D016301 10 associated lipids
Periapical Periodontitis D010485 6 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Angina, Unstable D000789 14 associated lipids
Vascular Diseases D014652 16 associated lipids
Pregnancy Complications, Hematologic D011250 11 associated lipids
Periapical Diseases D010483 4 associated lipids
Albuminuria D000419 18 associated lipids
Lymphocytosis D008218 2 associated lipids
Heart Valve Diseases D006349 4 associated lipids
Measles D008457 3 associated lipids
Hyperinsulinism D006946 27 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Acromegaly D000172 6 associated lipids
Familial Mediterranean Fever D010505 12 associated lipids
Celiac Disease D002446 16 associated lipids
Carotid Stenosis D016893 15 associated lipids
Periapical Granuloma D010484 3 associated lipids
HIV Infections D015658 20 associated lipids
Graves Disease D006111 6 associated lipids
Synovitis D013585 15 associated lipids
Carcinoma, Papillary D002291 3 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Arthritis, Psoriatic D015535 3 associated lipids
Atrial Fibrillation D001281 16 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Osteopetrosis D010022 1 associated lipids
Root Resorption D012391 2 associated lipids
Aortic Diseases D001018 11 associated lipids
Takayasu Arteritis D013625 3 associated lipids
Osteosclerosis D010026 2 associated lipids
Carcinoma, Neuroendocrine D018278 2 associated lipids
Hyperparathyroidism, Secondary D006962 4 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Sarcoma, Ewing D012512 2 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative D054438 1 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Prediabetic State D011236 1 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Hepatitis C D006526 7 associated lipids
Sclerosis D012598 5 associated lipids
Hyperostosis D015576 1 associated lipids
Legg-Calve-Perthes Disease D007873 1 associated lipids
Myositis, Inclusion Body D018979 3 associated lipids
Atherosclerosis D050197 85 associated lipids
Histiocytosis, Non-Langerhans-Cell D015616 4 associated lipids
Hearing Loss D034381 3 associated lipids
Musculoskeletal Diseases D009140 2 associated lipids
Histiocytosis, Langerhans-Cell D006646 1 associated lipids
Rupture, Spontaneous D012422 1 associated lipids
Bone Demineralization, Pathologic D018488 1 associated lipids
Temporomandibular Joint Disorders D013705 4 associated lipids
beta-Thalassemia D017086 5 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Radicular Cyst D011842 2 associated lipids
Ankylosis D000844 1 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Hyperparathyroidism D006961 3 associated lipids
Cholesteatoma, Middle Ear D018424 2 associated lipids
Neoplasms, Squamous Cell D018307 1 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Giant Cell Tumor of Bone D018212 1 associated lipids
Jaw Diseases D007571 4 associated lipids
Ossification, Heterotopic D009999 2 associated lipids
Hypercalciuria D053565 4 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Eye Neoplasms D005134 2 associated lipids
Diabetes, Gestational D016640 8 associated lipids
Chronic Periodontitis D055113 1 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
Dengue D003715 2 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Malnutrition D044342 6 associated lipids
Insulin Resistance D007333 99 associated lipids
Hemangioma, Capillary D018324 1 associated lipids
Neoplastic Syndromes, Hereditary D009386 1 associated lipids
Prenatal Exposure Delayed Effects D011297 2 associated lipids
Hot Flashes D019584 5 associated lipids
No-Reflow Phenomenon D054318 2 associated lipids
Vascular Calcification D061205 1 associated lipids
Peri-Implantitis D057873 1 associated lipids
Periodontal Attachment Loss D017622 7 associated lipids
Bone Cysts, Aneurysmal D017824 2 associated lipids
Diabetes Complications D048909 4 associated lipids
Pericardial Effusion D010490 2 associated lipids
Emphysema D004646 1 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Atrial Remodeling D064752 1 associated lipids
Hyperparathyroidism, Primary D049950 1 associated lipids
Lithiasis D020347 2 associated lipids
Osteoporotic Fractures D058866 1 associated lipids
Multiple Sclerosis, Chronic Progressive D020528 3 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Yamashita T et al. Retardation in bone resorption after bone marrow ablation in klotho mutant mice. 2000 Endocrinology pmid:10614667
Hofbauer LC et al. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. 2000 J. Bone Miner. Res. pmid:10646108
Kanzawa M et al. Involvement of osteoprotegerin/osteoclastogenesis inhibitory factor in the stimulation of osteoclast formation by parathyroid hormone in mouse bone cells. 2000 Eur. J. Endocrinol. pmid:10822231
Mukohyama H et al. The inhibitory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on osteoclast formation are associated with upregulation of osteoprotegerin and downregulation of RANKL and RANK. 2000 Biochem. Biophys. Res. Commun. pmid:10777696
Atkins GJ et al. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors. 2000 J. Bone Miner. Res. pmid:10780856
Thompson SW and Tonge D Bone cancer gain without the pain. 2000 Nat. Med. pmid:10802700
Honore P et al. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. 2000 Nat. Med. pmid:10802707
Onyia JE et al. In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene. 2000 J. Bone Miner. Res. pmid:10804015
Bateman TA et al. Osteoprotegerin mitigates tail suspension-induced osteopenia. 2000 Bone pmid:10773583
Malyankar UM et al. Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells. 2000 J. Biol. Chem. pmid:10811631
Thirunavukkarasu K et al. The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function. 2000 J. Biol. Chem. pmid:10833509
Aubin JE and Bonnelye E Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption. 2000 Medscape Womens Health pmid:10792853
Fata JE et al. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. 2000 Cell pmid:11051546
Miyamoto N et al. Spindle-shaped cells derived from giant-cell tumor of bone support differentiation of blood monocytes to osteoclast-like cells. 2000 J. Orthop. Res. pmid:11052502
Kaneda T et al. Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor. 2000 J. Immunol. pmid:11035059
Miyamoto T et al. An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand. 2000 Blood pmid:11110710
Proposed standard nomenclature for new tumor necrosis factor members involved in the regulation of bone resorption. The American Society for Bone and Mineral Research President's Committee on Nomenclature. 2000 Bone pmid:11113385
Takayanagi H et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. 2000 Nature pmid:11117749
Mancini L et al. Modulation of the effects of osteoprotegerin (OPG) ligand in a human leukemic cell line by OPG and calcitonin. 2000 Biochem. Biophys. Res. Commun. pmid:11118297
Lee ZH et al. Activation of c-Jun N-terminal kinase and activator protein 1 by receptor activator of nuclear factor kappaB. 2000 Mol. Pharmacol. pmid:11093794
Kong YY and Penninger JM Molecular control of bone remodeling and osteoporosis. 2000 Exp. Gerontol. pmid:11121682
Shalhoub V et al. Characterization of osteoclast precursors in human blood. 2000 Br. J. Haematol. pmid:11122091
Proposed standard nomenclature for new tumor necrosis factor family members involved in the regulation of bone resorption. The American Society for Bone and Mineral Research President's Committee on Nomenclature. 2000 J. Bone Miner. Res. pmid:11127193
Sakuma Y et al. Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype. 2000 Infect. Immun. pmid:11083800
Riggs BL The mechanisms of estrogen regulation of bone resorption. 2000 J. Clin. Invest. pmid:11086020
Udagawa N et al. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. 2000 Endocrinology pmid:10965921
Yasuda H [A new paradigm of osteoclast biology: discovery of OCIF and ODF]. 2000 Seikagaku pmid:10967683
Teitelbaum SL Bone resorption by osteoclasts. 2000 Science pmid:10968780
Lacey DL et al. Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. 2000 Am. J. Pathol. pmid:10934148
Quinn JM et al. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. 2000 J. Bone Miner. Res. pmid:10934644
Min H et al. Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. 2000 J. Exp. Med. pmid:10952716
Shiba H et al. Effects of ageing on proliferative ability, and the expressions of secreted protein, acidic and rich in cysteine (SPARC) and osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human periodontal ligament cells. 2000 Mech. Ageing Dev. pmid:10958924
López FJ New approaches to the treatment of osteoporosis. 2000 Curr Opin Chem Biol pmid:10959765
Nakashima T et al. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. 2000 Biochem. Biophys. Res. Commun. pmid:10973797
Itoh K et al. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors. 2000 J. Bone Miner. Res. pmid:10976996
Schinke T and Karsenty G Vascular calcification--a passive process in need of inhibitors. 2000 Nephrol. Dial. Transplant. pmid:10978374
Lorenzo J Interactions between immune and bone cells: new insights with many remaining questions. 2000 J. Clin. Invest. pmid:10995785
Teng YT et al. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. 2000 J. Clin. Invest. pmid:10995794
Børset M et al. Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins. 2000 Blood pmid:11001907
Capparelli C et al. Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy. 2000 Cancer Res. pmid:10706080
Makhluf HA et al. Age-related decline in osteoprotegerin expression by human bone marrow cells cultured in three-dimensional collagen sponges. 2000 Biochem. Biophys. Res. Commun. pmid:10679262
Merewether LA et al. Development of disulfide peptide mapping and determination of disulfide structure of recombinant human osteoprotegerin chimera produced in Escherichia coli. 2000 Arch. Biochem. Biophys. pmid:10683254
Ross FP RANKing the importance of measles virus in Paget's disease. 2000 J. Clin. Invest. pmid:10712423
Tricot G New insights into role of microenvironment in multiple myeloma. 2000 Lancet pmid:10675068
Takayanagi H et al. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. 2000 Arthritis Rheum. pmid:10693864
Itonaga I et al. Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages. 2000 Ann. Rheum. Dis. pmid:10627423
Chikatsu N et al. Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro. 2000 Biochem. Biophys. Res. Commun. pmid:10631114
Takami M et al. Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts. 2000 Endocrinology pmid:11108286
Gori F et al. The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. 2000 Endocrinology pmid:11108292
Clohisy DR et al. Osteoprotegerin inhibits tumor-induced osteoclastogenesis and bone tumor growth in osteopetrotic mice. 2000 J. Orthop. Res. pmid:11192258

Table of Content